Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Obesity × Aspirin × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 8 Polycythemia Vera 5 Prostatic Neoplasms 4 Neoplasms 4 Multiple Myeloma 4 Colonic Neoplasms 4 Cardiovascular Diseases 4 Venous Thromboembolism 3 Precancerous Conditions 3 Ovarian Neoplasms 3 Neoplasms, Plasma Cell 3 Myeloproliferative Disorders 3 Melanoma 3 Esophageal Neoplasms 3 Barrett Esophagus 3 Thrombosis 2 Thromboembolism 2 Thrombocythemia, Essential 2 Stomach Neoplasms 2 Rectal Neoplasms 2 Head and Neck Neoplasms 2 Adenomatous Polyps 2 Vascular Diseases 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Tobacco Use Disorder 1 Stroke 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor, Adult 1

Interventions

Exercise 14 Metformin 10 Methods 5 Exenatide 5 Diet 5 Resistance Training 4 Nutrition Assessment 4 Diet Therapy 4 Early Intervention, Educational 3 Counseling 3 Caloric Restriction 3 exemestane 2 Yoga 2 Vitamin D 2 Surveys and Questionnaires 2 Sugars 2 Nutritional Status 2 Naltrexone 2 Mindfulness-Based Stress Reduction 2 Educational Status 2 Docosahexaenoic Acids 2 Diet, Mediterranean 2 Cognitive Behavioral Therapy 2 Bupropion 2 Blood Specimen Collection 2 sibutramine 1 rosiglitazone-metformin combination 1 penclomedine 1 licogliflozin 1 dapagliflozin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02062255 2016-10-26

Impact of COX2 on Sera Biomarkers From Obese Subjects

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Completed

Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡